[1]
|
Stefan, Z.L., Harald, S., Andreas, F., et al. (2014) Antihyperglycaemic Therapies and Cancer Risk. Diabetes & Vascular Disease Research, 11, 371-389. https://doi.org/10.1177/1479164114549553
|
[2]
|
曹毛毛, 陈万青. GLOBOCAN 2020全球癌症统计数据解读[J]. 中国医学前沿杂志(电子版), 2021, 13(3): 63-69.
|
[3]
|
Hsing, A.W., Sakoda, L.C. and Chua, S. (2007) Obesity, Metabolic Syndrome, and Prostate Cancer. The American Journal of Clinical Nutrition, 86, 843S-857S. https://doi.org/10.1093/ajcn/86.3.843S
|
[4]
|
Luo, S., Li, J.Y., Zhao, L.N., et al. (2016) Diabetes Mellitus Increases the Risk of Colorectal Neoplasia: An Updated Meta-Analysis. Clinics and Research in Hepatology and Gastroenterology, 40, 110-123.
https://doi.org/10.1016/j.clinre.2015.05.021
|
[5]
|
Ryu, T.Y., Park, J. and Scherer, P.E. (2014) Hyperglycemia as a Risk Factor for Cancer Progression. Diabetes & Metabolism Journal, 38, 330-336. https://doi.org/10.4093/dmj.2014.38.5.330
|
[6]
|
Burton, A., Martin, R.M., Holly, J., et al. (2013) Associations of Adiponectin and Leptin with Stage and Grade of PSA-Detected Prostate Cancer: The Protect Study. Cancer Causes & Control: CCC, 24, 323-334.
https://doi.org/10.1007/s10552-012-0118-4
|
[7]
|
Gennigens, C., Menetrier-Caux, C. and Droz, J.P. (2006) Insu-lin-Like Growth Factor (IGF) Family and Prostate Cancer. Critical Reviews in Oncology/Hematology, 58, 124-145. https://doi.org/10.1016/j.critrevonc.2005.10.003
|
[8]
|
Tseng, C.H. (2011) Diabetes and Risk of Prostate Cancer: A Study Using the National Health Insurance. Diabetes Care, 34, 616-621. https://doi.org/10.2337/dc10-1640
|
[9]
|
Li, Q., Kuriyama, S., Kakizaki, M., et al. (2010) History of Diabetes Mellitus and the Risk of Prostate Cancer: The Ohsaki Cohort Study. Cancer Causes Control, 21, 1025-1032. https://doi.org/10.1007/s10552-010-9530-9
|
[10]
|
Bansal, D., Bhansali, A., Kapil, G., et al. (2013) Type 2 Diabetes and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies. Prostate Cancer and Prostatic Diseases, 16, 151-158. https://doi.org/10.1038/pcan.2012.40
|
[11]
|
Giovannucci, E., Harlan, D.M., Archer, M.C., et al. (2010) Diabetes and Cancer: A Consensus Report. CA: A Cancer Journal for Clinicians, 60, 207-221. https://doi.org/10.3322/caac.20078
|
[12]
|
Li, X., Li, J., Cai, Y., et al. (2018) Hyperglycaemia-Induced miR-301a Promotes Cell Proliferation by Repressing p21 and Smad4 in Prostate Cancer. Cancer Letters, 418, 211-220. https://doi.org/10.1016/j.canlet.2018.01.031
|
[13]
|
Vaupel, P., Schmidberger, H. and Mayer, A. (2019) The Warburg Effect: Essential Part of Metabolic Reprogramming and Central Contributor to Cancer Progression. International Journal of Radiation Biology, 95, 912-919.
https://doi.org/10.1080/09553002.2019.1589653
|
[14]
|
Hua, F., Yu, J.J. and Hu, Z.W. (2016) Diabetes and Cancer, Common Threads and Missing Links. Cancer Letters, 374, 54-61. https://doi.org/10.1016/j.canlet.2016.02.006
|
[15]
|
Albanes, D., Weinstein, S.J., Wright, M.E., et al. (2009) Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Prostate Cancer. JNCI: Journal of the National Cancer In-stitute, 101, 1272-1279.
https://doi.org/10.1093/jnci/djp260
|
[16]
|
Hsing, A.W., Gao, Y.T., Chua, S.J., et al. (2003) Insulin Resistance and Prostate Cancer Risk. JNCI: Journal of the National Cancer Institute, 95, 67-71. https://doi.org/10.1093/jnci/95.1.67
|
[17]
|
白培德, 黄海超, 秦家轩, 等. 糖尿病与前列腺癌发生及进展的关系研究[J]. 临床泌尿外科杂志, 2018, 33(6): 450-453.
|
[18]
|
Pandini, G., Frasca, F., Mineo, R., et al. (2002) Insu-lin/Insulin-Like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved. Journal of Biological Chemistry, 277, 39684-39695. https://doi.org/10.1074/jbc.M202766200
|
[19]
|
Hellawell, G.O., Turner, G.D., Davies, D.R., et al. (2002) Expres-sion of the Type 1 Insulin-Like Growth Factor Receptor Is Up-Regulated in Primary Prostate Cancer and Commonly Persists in Metastatic Disease. Cancer Research, 62, 2942-2950. https://doi.org/10.1016/S1569-9056(02)80120-8
|
[20]
|
Bermont, L., Lamielle, F., Lorchel, F., et al. (2001) Insulin Up-Regulates Vascular Endothelial Growth Factor and Stabilizes Its Messengers in Endometrial Adenocarcinoma Cells. The Journal of Clinical Endocrinology & Metabolism, 86, 363-368. https://doi.org/10.1210/jc.86.1.363
|
[21]
|
Angel, C.Z., Iguacel, I., Mullee, A., et al. (2020) Appetite-Regulating Hormones-Leptin, Adiponectin and Ghrelin- and the Development of Prostate Cancer: A Systematic Review and Exploratory Meta-Analysis. Prostate Cancer and Prostatic Diseases, 23, 11-23. https://doi.org/10.1038/s41391-019-0154-1
|
[22]
|
Aggarwal, B.B., Vijayalekshmi, R.V. and Sung, B. (2009) Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe. Clinical Cancer Research, 15, 425-430.
https://doi.org/10.1158/1078-0432.CCR-08-0149
|
[23]
|
Pothiwala, P., Jain, S.K. and Yaturu, S. (2009) Metabolic Syndrome and Cancer. Metabolic Syndrome and Related Disorders, 7, 279-288. https://doi.org/10.1089/met.2008.0065
|
[24]
|
Grossmann, M., Panagiotopolous, S., Sharpe, K., et al. (2009) Low Testosterone and Anaemia in Men with Type 2 Diabetes. Clinical Endocrinology (Oxford), 70, 547-553. https://doi.org/10.1111/j.1365-2265.2008.03357.x
|
[25]
|
Azoulay, L., Dell’Aniello, S., Gagnon, B., et al. (2011) Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes. Cancer Epidemiology, Biomarkers & Prevention, 20, 337-344.
https://doi.org/10.1158/1055-9965.EPI-10-0940
|
[26]
|
Evans, J.M., Donnelly, L.A., Emslie-Smith, A.M., et al. (2005) Metformin and Reduced Risk of Cancer in Diabetic Patients. BMJ, 330, 1304-1305. https://doi.org/10.1136/bmj.38415.708634.F7
|
[27]
|
Ben, S.I., Laurent, K., Loubat, A., et al. (2008) The Antidiabetic Drug Metformin Exerts an Antitumoral Effect in Vitro and in Vivo through a Decrease of Cyclin D1 Level. Oncogene, 27, 3576-3586. https://doi.org/10.1038/sj.onc.1211024
|
[28]
|
Seibel, S.A., Chou, K.H., Capp, E., et al. (2008) Effect of Metformin on IGF-1 and IGFBP-1 Levels in Obese Patients with Polycystic Ovary Syndrome. The European Journal of Obstetrics & Gynecology and Reproductive Biology, 138, 122-124. https://doi.org/10.1016/j.ejogrb.2007.02.001
|